Healthcare provider profile · identity verified

Michael A Benavides, DO

Family Practice · DALLAS, TX · NPI 1568497899

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	181
Lisinopril	Lisinopril	334	127
Metformin Hcl	Metformin Hcl	278	103
Losartan Potassium	Losartan Potassium	262	100
Levothyroxine Sodium	Levothyroxine Sodium	219	70
Amlodipine Besylate	Amlodipine Besylate	211	83
Simvastatin	Simvastatin	174	57
Gabapentin	Gabapentin	168	65
Pantoprazole Sodium	Pantoprazole Sodium	148	63
Rosuvastatin Calcium	Rosuvastatin Calcium	128	57
Omeprazole	Omeprazole	123	41
Alendronate Sodium	Alendronate Sodium	120	35
Furosemide	Furosemide	118	44
Albuterol Sulfate Hfa	Albuterol Sulfate	116	48
Meloxicam	Meloxicam	115	47
Carvedilol	Carvedilol	114	42
Azithromycin	Azithromycin	109	71
Metoprolol Succinate	Metoprolol Succinate	108	41
Tamsulosin Hcl	Tamsulosin Hcl	97	41
Metoprolol Tartrate	Metoprolol Tartrate	91	31
Trazodone Hcl	Trazodone Hcl	79	23
Januvia	Sitagliptin Phosphate	72	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	25
Buspirone Hcl	Buspirone Hcl	71	20
Clopidogrel	Clopidogrel Bisulfate	70	29
Methylprednisolone	Methylprednisolone	65	42
Olmesartan Medoxomil	Olmesartan Medoxomil	63	17
Allopurinol	Allopurinol	61	21
Hydrochlorothiazide	Hydrochlorothiazide	61	23
Pravastatin Sodium	Pravastatin Sodium	57	19
Baclofen	Baclofen	53	26
Farxiga	Dapagliflozin Propanediol	53	18
Fluticasone Propionate	Fluticasone Propionate	52	32
Nystatin	Nystatin	51	23
Triamcinolone Acetonide	Triamcinolone Acetonide	48	30
Glipizide	Glipizide	47	18
Mounjaro	Tirzepatide	47	13
Glimepiride	Glimepiride	46	19
Quetiapine Fumarate	Quetiapine Fumarate	45	11
Duloxetine Hcl	Duloxetine Hcl	44	15
Alprazolam	Alprazolam	42	12
Ozempic	Semaglutide	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	16
Sertraline Hcl	Sertraline Hcl	41	17
Eliquis	Apixaban	39	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	15
Potassium Chloride	Potassium Chloride	38	15
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	37	suppressed
Jardiance	Empagliflozin	37	15
Mirtazapine	Mirtazapine	37	12
Clonidine Hcl	Clonidine Hcl	36	13
Escitalopram Oxalate	Escitalopram Oxalate	35	13
Amoxicillin	Amoxicillin	34	28
Cephalexin	Cephalexin	34	31
Nateglinide	Nateglinide	34	12
Lantus	Insulin Glargine,hum.Rec.Anlog	33	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	22
Metformin Hcl Er	Metformin Hcl	31	12
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Hydralazine Hcl	Hydralazine Hcl	30	11
Symbicort	Budesonide/Formoterol Fumarate	30	12
Terbinafine Hcl	Terbinafine Hcl	30	20
Esomeprazole Magnesium	Esomeprazole Magnesium	28	12
Ibuprofen	Ibuprofen	28	13
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	12
Donepezil Hcl	Donepezil Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Naproxen	Naproxen	24	13
Celecoxib	Celecoxib	23	12
Lovastatin	Lovastatin	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Ondansetron Hcl	Ondansetron Hcl	22	15
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	18
Finasteride	Finasteride	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Famotidine	Famotidine	19	11
Memantine Hcl	Memantine Hcl	19	suppressed
Primidone	Primidone	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Risperidone	Risperidone	15	suppressed
Colchicine	Colchicine	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Testosterone	Testosterone	13	suppressed
Torsemide	Torsemide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Bepotastine Besilate	Bepotastine Besilate	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Linzess	Linaclotide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error